Spectral AI Announces Collaboration with Global Wound Care Company PolyNovo to Introduce DeepView System for Burn Indication to Australian Market

6 days ago

DALLAS, July 08, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance

6 days ago

            MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenuesand Raises 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM…

Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors

6 days ago

            Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors IRVINE, CA, and HERSTAL, BELGIUM – July 8,…

CBIH Charts Path to Future Leadership in Cannabis Medicine

6 days ago

A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience…

Aerovate Therapeutics to Explore Strategic Alternatives

6 days ago

WALTHAM, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), which previously announced it was halting enrollment…

ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan

6 days ago

For the treatment of Borderline Personality Disorder (BPD) and Attention Deficit Hyperactivity disorder (ADHD)MADRID and CAMBRIDGE, Mass., July 08, 2024…

Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

6 days ago

Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia Approximately 10 million adults in…

Safety Shot Terminates Partnership With Brand Ambassador Ryan Garcia Following Disparaging Remarks

6 days ago

Safety Shot Has Zero-Tolerance For Any Sort Of Hate Speech JUPITER, FL, July 08, 2024 (GLOBE NEWSWIRE) -- Safety Shot,…

Belite Bio to Present at the JonesHealthcare Seaside Summit

6 days ago

SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused…